Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV-DDI”

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT00214435
What this trial is testing

Once Daily 3TC, Efavirenz and ddI for HIV Infection

Who this might be right for
HIV InfectionAIDS
407 Doctors 120
Post-approval studies (Phase 4)Study completedNCT00358696
What this trial is testing

Antiretroviral Switch From Didanosine to Tenofovir in HIV/HCV Co-infected Patients

Who this might be right for
HIVHIV Infections
University of British Columbia 30
Post-approval studies (Phase 4)Study completedNCT00005764
What this trial is testing

Increased Lactic Acid and Abnormal Fat Distribution in HIV-Positive Patients

Who this might be right for
HIV InfectionsLipodystrophy
Glaxo Wellcome 100
Not applicableStudy completedNCT00002168
What this trial is testing

A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients

Who this might be right for
HIV Infections
Bristol-Myers Squibb 200
Testing effectiveness (Phase 2)Study completedNCT00016718
What this trial is testing

Safety and Effectiveness of Emtricitabine, Efavirenz, and Didanosine in HIV Infected Children Who Have Taken Few or No Anti-HIV Drugs

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 43
Early research (Phase 1)Study completedNCT01731574
What this trial is testing

DDI Potential: Dapivirine Vaginal Ring and Miconazole Nitrate

Who this might be right for
HIV
International Partnership for Microbicides, Inc. 36
Not applicableStudy completedNCT00001997
What this trial is testing

Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine or Dideoxyinosine in HIV Positive, Asymptomatic and Symptomatic Individuals

Who this might be right for
HIV Infections
Chiron Corporation
Early research (Phase 1)Study completedNCT00002313
What this trial is testing

Nystatin in HIV-Infected Patients

Who this might be right for
HIV Infections
Argus Pharmaceuticals
Early research (Phase 1)Study completedNCT00002360
What this trial is testing

A Study Comparing Two Forms of Didanosine in HIV-infected Patients

Who this might be right for
HIV Infections
Bristol-Myers Squibb 30
Testing effectiveness (Phase 2)Study completedNCT00000823
What this trial is testing

Phase II Double-Blind Exploratory Study to Evaluate Differences Among Various Zidovudine/Didanosine Regimens on Quantitative Measures of Viral Burden in Relatively Early HIV-1 Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 85
Large-scale testing (Phase 3)UnknownNCT00008489
What this trial is testing

Comparing Side Effects of Two Forms of Videx in HIV-Infected Adults

Who this might be right for
HIV Infections
PharmaResearch 200
Early research (Phase 1)Study completedNCT00000760
What this trial is testing

Study of Activity, Safety, and Tolerance of Oral Ro 24-7429 (Tat Antagonist) in Patients With HIV Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 96
Early research (Phase 1)Study completedNCT02480894
What this trial is testing

A Open-label, Drug-Drug Interaction With Maraviroc (DDI)

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 112
Large-scale testing (Phase 3)UnknownNCT00006397
What this trial is testing

Differences Between Women and Men Taking a Combination of Indinavir, Ritonavir, Enteric-Coated Didanosine, and Stavudine Who Previously Took Anti-HIV Drugs

Who this might be right for
HIV Infections
PPD Development, LP 200
Testing effectiveness (Phase 2)Study completedNCT00000803
What this trial is testing

A Phase II Double-Blind Study of Delavirdine Mesylate ( U-90152 ) in Combination With Zidovudine ( AZT ) and/or Didanosine ( ddI ) Versus AZT and ddI Combination Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 471
Testing effectiveness (Phase 2)Study completedNCT00001045
What this trial is testing

Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients With No Symptoms of the Disease

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 300
Testing effectiveness (Phase 2)Temporarily pausedNCT00668356
What this trial is testing

Bioequivalence Study of Didanosine in Children Treated for HIV

Who this might be right for
HIV Infections
Assistance Publique - Hôpitaux de Paris 26
Early research (Phase 1)Study completedNCT00920296
What this trial is testing

DDI Study of Etravirine and GSK1265744

Who this might be right for
Healthy SubjectsInfection, Human Immunodeficiency Virus
GlaxoSmithKline 12
Testing effectiveness (Phase 2)Ended earlyNCT00002420
What this trial is testing

The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors

Who this might be right for
HIV Infections
Bristol-Myers Squibb 25
Not applicableStudy completedNCT00002035
What this trial is testing

Double-Blind Comparison of the Efficacy of Continued Zidovudine Versus 2',3'-Dideoxyinosine (ddI) (BMY-40900) for the Treatment of Patients With AIDS or AIDS-Related Complex and Increasing Symptomatology Despite Treatment With Zidovudine

Who this might be right for
HIV Infections
Bristol-Myers Squibb 300
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation